Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $7.49 USD
Change Today -0.24 / -3.10%
Volume 1.5M
As of 8:10 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

J. Joseph Kim Ph.D.

Chief Executive Officer, President, Director and Member of Finance Committee,Inovio Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 11 board members in 3 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. J. Joseph Kim, Ph.D has been the Chief Executive Officer of Inovio Pharmaceuticals, Inc. (alternate name: Inovio Biomedical Corp) since June 1, 2009 and has been its President since October 6, 2009. Dr. Kim co-founded ADViSYS Inc., a subsidiary of Viral Genomix in 1997 and serves as its Chief Executive Officer and President. He co-founded VGX Pharmaceuticals, LLC (Formerly Viral Genomix, Inc) in 2000 and served as its Chief Executive Officer and President from 2000 ...

Read Full Background

Corporate Headquarters*

660 West Germantown Pike
Plymouth Meeting, Pennsylvania 19462

United States

Phone: 267-440-4200
Fax: 267-440-4242

Board Members Memberships*

Co-Founder, Chief Executive Officer, President and Director
Chief Executive Officer, President, Director and Member of Finance Committee


Massachusetts Institute of Technology
The University of Pennsylvania
University of Pennsylvania - The Wharton School

Other Affiliations*

Annual Compensation*

Total Annual Compensation$964,664

Stock Options*

All Other Compensation$10,620
Exercisable Options798,177
Unexercisable Options173,438
Total Number of Options971,615

Total Compensation*

Total Annual Cash Compensation$975,284
Total Short Term Compensation$964,664
Other Long Term Compensation$10,620
Total Calculated Compensation$2,104,392
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INO:US $7.49 USD -0.24


Vijay B. Samant Chief Executive Officer, President, Acting Chief Financial Officer and Director
Vical Incorporated
Steven W. King Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc
Peregrine Pharmaceuticals, Inc.
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
Daniel J. O'Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
William D. Clark Chief Executive Officer, President and Director
Genocea Biosciences, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INOVIO PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at